BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 6395656)

  • 1. Immunohistological analysis of human lymphoma: correlation of histological and immunological categories.
    Stein H; Lennert K; Feller AC; Mason DY
    Adv Cancer Res; 1984; 42():67-147. PubMed ID: 6395656
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunopathology in lymphatic systemic diseases].
    Huber H; Huber C; Michlmayr G
    Verh Dtsch Ges Inn Med; 1973; 79():159-67. PubMed ID: 4133402
    [No Abstract]   [Full Text] [Related]  

  • 3. Surface markers for T and B lymphocytes in normals and patients with lymphoproliferative disorders.
    Cohnen G; Augener W; Douglas SD; König E; Brittinger G
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:295. PubMed ID: 4605188
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunologic approach to non-Hodgkin lymphomas and related leukemias. Analysis of the results of multiparameter studies of 425 cases.
    Lukes RJ; Parker JW; Taylor CR; Tindle BH; Cramer AD; Lincoln TL
    Semin Hematol; 1978 Oct; 15(4):322-51. PubMed ID: 366759
    [No Abstract]   [Full Text] [Related]  

  • 5. [Culture of peripheral lymphocytes in chronic malignant lymphoadenopathies].
    Giraudo Conesa LC; Braun M; Bachmann AE; Pavlovsky A
    Prensa Med Argent; 1971 Aug; 58(23):1160-2. PubMed ID: 4940640
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation between the presence of surface localized immunoglobulin (Ig) and the histological type of human malignant lymphomas.
    Johansson B; Klein E; Haglund S
    Clin Immunol Immunopathol; 1976 Jan; 5(1):119-32. PubMed ID: 816584
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunoglobulins in lymphoma].
    van Camp B; Peetermans M
    Acta Clin Belg; 1975; 30(4):272-6. PubMed ID: 1108566
    [No Abstract]   [Full Text] [Related]  

  • 8. [Significance of the HL-A-antigensystem in tumor research].
    Kuwert E; Bertrams J
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1972; 78(2):204-18. PubMed ID: 4264844
    [No Abstract]   [Full Text] [Related]  

  • 9. The investigation of the immunological reactivity of patients with haemoblastosis.
    Libánský J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1965; 84(2):172-89. PubMed ID: 4161254
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of serum immunoglobulins in patients with lymphohistiocytic proliferative disorders].
    Sciancalepore G; Casellato MM; Lugaro G ARONEA ; Bosi L; Caprio G
    Tumori; 1969; 55(1):27-38. PubMed ID: 4182973
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of antilymphocyte globulin as a study method in the identification of lymphoid antigens expressed by populations of leukemic and/or lymphomatous cells].
    Marmont A
    Minerva Med; 1978 Apr; 69(18):1263-74. PubMed ID: 351459
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunologic characterization of human malignant lymphomas.
    Lukes RJ; Collins RD
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1488-503. PubMed ID: 4608683
    [No Abstract]   [Full Text] [Related]  

  • 13. [Reactivity of the lymphocytes of lymph nodes in cases of malignant lymphoma to plant agglutinin].
    Stramignoni A; Navone R; Meriggi E
    Boll Soc Ital Biol Sper; 1969 Feb; 45(3):194-6. PubMed ID: 4899663
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphocyte transformation in diseases of lymphoid tissue.
    Pentycross CR
    Proc R Soc Med; 1970 Apr; 63(4):355-7. PubMed ID: 4909839
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lymphomas and immunity].
    Kouvalainen K
    Duodecim; 1970; 86(16):886-94. PubMed ID: 4917099
    [No Abstract]   [Full Text] [Related]  

  • 16. [Malignant lymphoma--classification and pathophysiological characteristics of neoplastic cells based on the nature of cell membrane].
    Shimoyama M; Minato K; Kimura K
    Nihon Rinsho; 1976 May; 34(5):925-33. PubMed ID: 789941
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunologic abnormalities in patients with malignant lymphoproliferative diseases.
    Hunter CP; Tannenbaum H; Churchill WH; Moloney WC; Schur PH
    J Natl Cancer Inst; 1977 May; 58(5):1185-90. PubMed ID: 323504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current trends in therapy and prophylaxis of immunological disorders in malignant hemoreticulopathies].
    Berceanu S; Gociu M
    Stud Cercet Med Interna; 1969; 10(3):197-208. PubMed ID: 4186583
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blastic lymphocyte transformation caused by phytohemagglutinin in patients with lymphoproliferative diseases].
    Mantovani G; Petrini MT; Tognella S; Grifoni V
    Boll Soc Ital Biol Sper; 1972 Jul; 48(14):381-5. PubMed ID: 4628299
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunodeficiency and lymphomas].
    Leoni P; Montroni M; Montillo M; Centurioni R; Salvi A; Fanciulli E
    G Clin Med; 1981 Sep; 62(9):648-55. PubMed ID: 7033028
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.